QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
NYSE:ELAN

Elanco Animal Health (ELAN) Stock Forecast, Price & News

$9.06
-0.29 (-3.10%)
(As of 06/9/2023 ET)
Compare
Today's Range
$9.05
$9.37
50-Day Range
$8.09
$10.17
52-Week Range
$7.88
$23.32
Volume
3.55 million shs
Average Volume
7.70 million shs
Market Capitalization
$4.46 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50

Elanco Animal Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
82.1% Upside
$16.50 Price Target
Short Interest
Healthy
1.59% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-4.69
Upright™ Environmental Score
News Sentiment
1.14mentions of Elanco Animal Health in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$144,000 Bought Last Quarter
Proj. Earnings Growth
11.25%
From $0.80 to $0.89 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

264th out of 987 stocks

Pharmaceutical Preparations Industry

116th out of 477 stocks


ELAN stock logo

About Elanco Animal Health (NYSE:ELAN) Stock

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants &

Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

ELAN Stock News Headlines

Zoetis Declares New Dividend, Hinting At Undervaluation
Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally
Animal Wound Care Global Market Report 2023
[BREAKING] Small Firm Develops World's First Anti-Aircraft Laser
Small cap wins $1.65 billion contract to make them. GlobeNewswire says this is a $51.1 Billion market by 2026. See why this stock could soar 2,476% >>>
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Elanco's Canine Parvovirus Treatment Gets USDA License
See More Headlines

ELAN Price History

ELAN Company Calendar

Last Earnings
5/09/2023
Today
6/09/2023
Next Earnings (Estimated)
8/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.50
High Stock Price Forecast
$22.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+80.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
7 Analysts

Profitability

Net Income
$-78,000,000.00
Pretax Margin
-0.88%

Debt

Sales & Book Value

Annual Sales
$4.44 billion
Cash Flow
$2.52 per share
Book Value
$15.37 per share

Miscellaneous

Free Float
461,028,000
Market Cap
$4.50 billion
Optionable
Optionable
Beta
0.92

Key Executives

  • Jeffrey N. SimmonsJeffrey N. Simmons
    President, Chief Executive Officer & Director
  • Todd S. YoungTodd S. Young
    Chief Financial Officer & Executive Vice President
  • Christopher Keeley
    Chief Information Officer & Senior Vice President
  • Ramiro M. Cabral
    Executive VP & President-Elanco International
  • Marcela A. Kirberger
    Secretary, Executive VP & General Counsel













ELAN Stock - Frequently Asked Questions

Should I buy or sell Elanco Animal Health stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last year. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ELAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ELAN, but not buy additional shares or sell existing shares.
View ELAN analyst ratings
or view top-rated stocks.

What is Elanco Animal Health's stock price forecast for 2023?

7 Wall Street research analysts have issued 1 year price objectives for Elanco Animal Health's stock. Their ELAN share price forecasts range from $12.00 to $22.00. On average, they predict the company's share price to reach $16.50 in the next year. This suggests a possible upside of 80.7% from the stock's current price.
View analysts price targets for ELAN
or view top-rated stocks among Wall Street analysts.

How have ELAN shares performed in 2023?

Elanco Animal Health's stock was trading at $12.22 at the beginning of 2023. Since then, ELAN stock has decreased by 25.3% and is now trading at $9.13.
View the best growth stocks for 2023 here
.

Are investors shorting Elanco Animal Health?

Elanco Animal Health saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 7,850,000 shares, a decline of 28.4% from the April 30th total of 10,970,000 shares. Based on an average daily trading volume, of 7,620,000 shares, the short-interest ratio is presently 1.0 days.
View Elanco Animal Health's Short Interest
.

When is Elanco Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our ELAN earnings forecast
.

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health Incorporated (NYSE:ELAN) posted its quarterly earnings data on Tuesday, May, 9th. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.16. The firm earned $1.26 billion during the quarter, compared to analysts' expectations of $1.18 billion. Elanco Animal Health had a positive trailing twelve-month return on equity of 8.21% and a negative net margin of 0.49%. The business's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share (EPS) guidance of $0.76-$0.83 for the period, compared to the consensus EPS estimate of $0.78. The company issued revenue guidance of $4.31 billion-$4.40 billion, compared to the consensus revenue estimate of $4.33 billion.

What is Jeff Simmons' approval rating as Elanco Animal Health's CEO?

169 employees have rated Elanco Animal Health Chief Executive Officer Jeff Simmons on Glassdoor.com. Jeff Simmons has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), QUALCOMM (QCOM), Walt Disney (DIS), Johnson & Johnson (JNJ), AT&T (T), Cisco Systems (CSCO), CVS Health (CVS) and Bristol-Myers Squibb (BMY).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "ELAN."

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (5.91%), Shapiro Capital Management LLC (4.11%), Price T Rowe Associates Inc. MD (3.52%), JPMorgan Chase & Co. (2.25%), State Street Corp (2.14%) and Black Creek Investment Management Inc. (2.08%). Insiders that own company stock include Aktiengesellschaft Bayer, Art A Garcia, Elanco Animal Health Inc, Jeffrey N Simmons, John P Bilbrey, Michael J Harrington, R David Hoover, Rajeev A Modi and Todd S Young.
View institutional ownership trends
.

How do I buy shares of Elanco Animal Health?

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $9.13.

How much money does Elanco Animal Health make?

Elanco Animal Health (NYSE:ELAN) has a market capitalization of $4.50 billion and generates $4.44 billion in revenue each year. The company earns $-78,000,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How many employees does Elanco Animal Health have?

The company employs 9,000 workers across the globe.

How can I contact Elanco Animal Health?

Elanco Animal Health's mailing address is 2500 INNOVATION WAY, GREENFIELD IN, 46140. The official website for the company is www.elanco.com. The company can be reached via phone at (877) 352-6261 or via email at kanaga_tiffany@elanco.com.

This page (NYSE:ELAN) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -